Calcium citrate

Calcium citrate has been studied in 4 papers since 2007: 3 trials in people, 1 in animals. The newest paper, Feb 12, 2024: “Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study”.

Intervention

4 papers study it8 more mention it4 findingsUpdated

PubChemChEBIMeSH

See all 12 papers on calcium citrate

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries; 3 trials, none about aging.

“Both systolic and diastolic blood pressure decreased from baseline to follow-up visit (change of -2.8 ± 13.9 mmHg, p = 0.0102 and -2.1 ± 10.4 mmHg, p = 0.0116, respectively).”
Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter studyAging clinical and experimental research2024doi:10.1007/s40520-024-02696-9

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • 3 trials, none about aging
  • Funders: Auckland Medical Research Foundation and 8 more
  • 2 of 4 findings with company ties
  • Human trial3
  • Animals1

Studies in people

2 studies gave calcium citrate to people and measured what changed.

What changedDesignPeopleSource

down: Decreases diastolic blood pressure79.5 ± 8.7 mmHg to 77.4 ± 8.6 mmHg

Trialwithin 12 months268 people245 females (91.4%) and 23 males (8.6%)70.0 ± 4.5 yearsOlder adults; Patient cohortsAging clinical and experimental research, Feb 12, 2024

no change: Has no effect on diastolic blood pressure

up: Increases serum calcium

Randomized trial6 hours40 peopleWomenmean age 71 yearsOlder adults; Postmenopausal women; Healthy postmenopausal womenOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Aug 20, 2016

What did studies of calcium citrate find?

3

Studies of calcium citrate measured 3 outcomes: diastolic blood pressure, serum calcium and diastolic blood pressure.

Diastolic blood pressure

downin humans1

1 study
  1. Calcium citrate decreases diastolic blood pressure in humans (79.5 ± 8.7 mmHg to 77.4 ± 8.6 mmHg).

    “Likewise, DBP was also seen to decrease from 79.5 ± 8.7 mmHg to 77.4 ± 8.6 mmHg (baseline to V2) (p = 0.0116).”

    Human trialwithin 12 months

    Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study

    Aging clinical and experimental research

  2. Calcium citrate decreases diastolic blood pressure in humans (osteopenia) (-2.1 ± 10.4 mmHg, p = 0.0116).

    “Both systolic and diastolic blood pressure decreased from baseline to follow-up visit (change of -2.8 ± 13.9 mmHg, p = 0.0102 and -2.1 ± 10.4 mmHg, p = 0.0116, respectively).”

    Human trialosteopenia500 mg dailyup to one yearn = 268

    Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study

    Aging clinical and experimental research

More on Diastolic blood pressure

Serum calcium

upin humans1

1 study
  1. Calcium citrate increases serum calcium in humans (Healthy postmenopausal women; compared with placebo).

    “Ionised and total calcium concentrations increased after calcium (p < 0.0001 versus placebo).”

    Human trialHealthy postmenopausal women; compared with placebocitrateserum1 g of calcium6 hoursfemalesn = 40

    Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

More on Serum calcium

Diastolic blood pressure

no changein humans1

1 study
  1. Calcium citrate showed no clear effect on diastolic blood pressure in humans (Healthy postmenopausal women; compared with placebo).

    “The reduction in diastolic blood pressure was similar after calcium and placebo.”

    Human trialHealthy postmenopausal women; compared with placebocitrate1 g of calcium6 hoursfemalesn = 40

    Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 02 papers in 12 months

See all 12 papers on calcium citrate